Revenue segments as reported by the company.

Premiums

Services

Investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefits

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Humana

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental plans such as Medicare, and State-based contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance. The Healthcare Services segment offers services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics to other Humana businesses, as well as external health plan members, and other employers. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Humana exceeds earnings expectations, focuses on value-based care growth

Humana's strong financial performance and growth in value-based care position the company well for future success. Addressing audit error rates, uncertainties around RADV, and managing costs are key challenges. Opportunities in recruiting, revenue growth, and strategic partnerships offer avenues for further growth.

Humana exceeds Q1 expectations, eyes industry growth amidst challenges

Humana's strong Q1 performance and strategic decisions position it well for growth
Challenges like rate disruptions and Medicaid redeterminations require close monitoring
Opportunities in industry growth, member engagement, and benefit enhancements ahead
Commitment to long-term goals and high-quality service evident in company's outlook

Humana meets Q2 expectations, eyes growth in MA platform

Humana's Q2 performance met expectations with a focus on MA platform growth and disciplined investments.
Challenges include higher utilization in Medicare Advantage and broad-based medical cost trends.
Strategic benefits adjustments and competitive positioning present opportunities for growth and margin expansion.
Expectations for 2024 include maintaining market share, offsetting costs, and achieving strong membership growth.

Humana surpasses Q3 earnings expectations, eyes $37 EPS target

Humana's Q3 performance exceeded expectations, with strong membership growth and strategic initiatives driving future profitability.
While facing challenges in benefit ratios and regulatory changes, Humana remains focused on achieving long-term financial targets.
The company's commitment to operational excellence, membership growth, and pricing actions positions it for sustained success.
Strategic partnerships and risk management efforts showcase Humana's resilience and adaptability in a dynamic healthcare landscape.

Humana faces challenges from rising costs but eyes long-term growth

Humana's Q4 2023 earnings call highlighted challenges from increased medical costs and utilization trends impacting financial performance and outlook.
Despite disappointments in short-term results, the company remains confident in the long-term attractiveness of the Medicare Advantage sector.
Strategic efforts to restore margins, address utilization drivers, and engage with providers reflect a proactive approach to managing industry dynamics.
Balancing profitability with membership growth through benefit adjustments and pricing actions is crucial for Humana's sustainable financial performance.

Humana reports solid Q1 performance, eyes margin recovery in 2025

Humana's Q1 2024 earnings call highlighted a strong start to the year, challenges in the industry for 2025, and a focus on margin recovery and growth opportunities. The company remains confident in its outlook, emphasizing pricing discipline and maintaining a strong value proposition in the market.

Humana surpasses Q2 expectations, addresses cost pressures for growth

Humana's Q2 2024 performance exceeded expectations, driven by strong Medicare business and growth in Medicaid and primary care segments.
Challenges such as medical cost pressures were addressed through mitigation measures, while opportunities lie in strategic initiatives and long-term planning.
The company's focus on value, disciplined cost management, and operational efficiency position it well for sustained growth and value creation.

Humana surpasses Q3 expectations, eyes growth through efficiency and investments

Humana's Q3 performance exceeded expectations, with a focus on balancing earnings and investments. The company is strategically positioned to drive growth through membership expansion and operational efficiency. Challenges include managing costs and understanding market dynamics, with opportunities in improving Stars ratings and expanding senior care services.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Healthy Horizons in Kentucky Announces $207,000 Investment to Reduce “Digital Divide” and Improve Access to Health Care in Lyon County, KY

Humana Healthy Horizons in Kentucky Announces $207,000 Investment to Reduce “Digital Divide” and Improve Access to Health Care in Lyon County, KY

HARTFORD, Conn.--(BUSINESS WIRE)--For first time, Humana offering Medicare Advantage plans in Connecticut.

For First Time, Humana Offering Medicare Advantage Plans in Connecticut

CVS Health

Doximity

All three of these telehealth companies are already profitable and have solid financials.

3 Leading Telehealth Stocks to Buy in 2021 and Beyond

BOSTON, Oct. 13, 2021 /PRNewswire/ -- Today Cohere Health, an emerging high-growth digital health company, announced that Humana Inc. (NYSE: HUM) is embarking on a nationwide expansion of Cohere's digital authorization platform for musculoskeletal (MSK) services, based on the success of its initial implementation. After rolling out the platform across 12 states in January 2021, Humana has made significant progress toward achieving its vision to reimagine and modernize processes for prior authorization by reducing approval times, increasing provider satisfaction, and improving delivery of care, all while preserving important benefits such as safety, predictability, and reducing waste.

Cohere Health Announces National Expansion of Humana Partnership to Transform Prior Authorization Process

NASHVILLE, Tenn.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) today announced another major expansion of its Medicare Advantage (MA) offerings across Tennessee for the 2022 plan year. It's part of the company's strategy to increase affordable Medicare health plan options that address the whole person health care needs of Tennesseans. In addition, for all Humana 2022 MA plan members with a COVID diagnosis, there is $0 copay for testing, treatment, vaccinations

Humana Continues Extensive Statewide Expansion in Tennessee

Humana (HUM) declares enhanced health plans for its customers to opt for in the 2022 Medicare AEP period. The company will foray into newer counties to offer improved health outcomes.

Humana's (HUM) 2022 Expansion Plan to Boost MA Customer Base

Biogen

Biogen continues to deal with the aftermath of allegedly paying co-pays for some Medicare patients.

Why Humana Is Suing Biogen

NASHVILLE, Tenn.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) today announced that its statewide Humana HMO Medicare Advantage plan in Tennessee has once again achieved the highest possible 5-star rating from the Centers for Medicare & Medicaid Services (CMS). The 5-star Humana HMO plan, which also attained the highest rating for 2019, today is offered in all of Tennessee's 95 counties. The plan is one of four Humana plans in the nation that received a 5-s

For Second Time, Humana Tennessee Medicare Advantage HMO Plan Achieves Highest Quality Rating

NEW ORLEANS--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), one of the nation's leading health and well-being companies, has announced that its Humana Health Benefit Plan of Louisiana, Inc. HMO plan has received the highest possible quality rating for the 2022 plan year from the Centers for Medicare and Medicaid Services (CMS). The Louisiana Medicare Advantage HMO plan, which is offered statewide and has more than 185,000 members as of September 2021, is one of four Humana plans in the nation that r

Humana Louisiana Medicare Advantage HMO Plan Achieves Prestigious 5-Star Rating

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), one of the nation's leading health and well-being companies, has announced that its Kentucky HMO plan offered through Humana Health Plan of Ohio, Inc. has received the highest possible quality rating for the 2022 plan year from the Centers for Medicare and Medicaid Services (CMS). The Kentucky HMO plan, which is offered in Boone, Campbell, Grant, Kenton and Pendleton counties in Kentucky, is one of four of Humana's Medicare Advantage pl

Humana Kentucky Medicare Advantage HMO Plan Receives Prestigious 5-Star Rating

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), one of the nation's leading health and well-being companies, today announced the Medicare Star Ratings for its Medicare Advantage (MA) plans, effective January 1, 2022, from the Centers for Medicare and Medicaid Services (CMS). CMS posts Star Ratings at www.medicare.gov. With these results, Humana's Star Ratings continue to reflect the company's strong focus on ensuring high quality of care, patient-centered clinical outcomes and reliab

97% of Humana's Medicare Advantage Members Are in Contracts Rated 4-Star or Higher for 2022, Reflecting Strong Commitment to Quality of Care, Patient-Centered Clinical Outcomes and Customer Service

GREENVILLE, N.C.--(BUSINESS WIRE)--Humana expands access to affordable Medicare options in Eastern North Carolina.

Humana Expands Access to Affordable Medicare Options in Eastern North Carolina

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Foundation donates $200,000 to recovery efforts for Louisianans impacted by Hurricane Ida.

Humana Foundation Donates $200,000 to Recovery Efforts for Louisianans Impacted by Hurricane Ida

Applied Materials

Activision Blizzard

Cintas Corp

Domino's Pizza

Expeditors International of Washington

Home Depot

Intercontinental Exchange

Intuit

Lockheed Martin

Lowe's

Lam Research

Mastercard

Moody's

MarketAxess Holdings

Monolithic Power Systems

Morgan Stanley

MSCI

Microsoft

NVIDIA

Roper Technologies

Charles Schwab

Sherwin-Williams

Thermo Fisher Scientific

T. Rowe Price Group

I present 30 High Growth Dividend Stocks for consideration in October 2021. The watchlist from September 2021 had a -4.14% return last month beating both VIG and SPY.

High Growth Dividend Stocks For October 2021

LOUISVILLE, Ky.--(BUSINESS WIRE)--Louisville nonprofits awarded $1.8 million through The Humana Foundation's Community Partners Program.

Louisville Nonprofits Awarded $1.8 Million Through the Humana Foundation's Community Partners Program

Alibaba

Bristol-Myers

Verizon

With the S&P 500 up 30.65% year over year and the Buffett Indicator showing the U.S. stock market as “significantly overvalued” with an implied future return of -2.5% per year, it may feel like there are no more value opportunities left.

5 Popular Guru Stocks Trading Near 52-Week Lows

Cigna

UnitedHealth Group

Several health insurers including Cigna Corp. CI, -1.85% , Humana Inc. HUM, -1.57% , and UnitedHealth Group Inc. UNH, -2.42% announced Friday that they are expanding their geographic presence in the Medicare Advantage market. The annual election period for Medicare is between Oct. 15 and Dec. 7 for 2022.

Cigna, Humana, UnitedHealth to expand into new Medicare Advantage markets in 2022

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana expanding Medicare Advantage health plans in 2022 to address beneficiaries' most important needs.

Humana Expanding Medicare Advantage Health Plans in 2022 to Address Beneficiaries' Most Important Needs, Delivering Predictable, Affordable and Understandable Health Care

JACKSON, Miss.--(BUSINESS WIRE)--The University of Mississippi Medical Center and Humana sign agreement, expanding Humana's Medicare Advantage provider network.

The University of Mississippi Medical Center and Humana Sign Agreement, Expanding Humana's Medicare Advantage Provider Network in Jackson, Lexington and Grenada

We think that Humana stock currently is a better pick compared to Cigna stock, despite Humana being more expensive of the two. Humana trades at about 0.7x trailing revenues, compared to 0.4x for Cigna.

Here's Why Humana Stock May See Higher Levels

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the third quarter 2021 (3Q21) on Wednesday, November 3, 2021 at 6:30 a.m. Eastern time. The company will host a conference call at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2021. All interested parties are invited to dial 888-625-7430. No password is required. A webcast of the 3Q21 earnings call may also be accessed via Humana's In

Humana Inc. to Release Third Quarter 2021 Results on November 3, 2021

While Humana Inc.'s (NYSE:HUM) stock already seems to price in the near-term concerns around rebounding medical costs and high COVID-19 costs, it offers an opportunity to gain exposure to “the post-COVID accelerating growth environment and associated 2022 inflection,” according to SVB Leerink. The Humana Analyst: Whit Mayo initiated coverage of Humana with an Outperform rating and a price target of $494.

Why Did SVB Leerink Initiate Humana With Outperform?

Humana (HUM) inks a deal with Kelsey-Seybold Clinic in Houston to offer its Humana Medicare Advantage HMO members enriched healthcare facilities.

Humana (HUM), Kelsey-Seybold Clinic Tie Up for Better Healthcare

HOUSTON--(BUSINESS WIRE)--Humana and Kelsey-Seybold Clinic team to expand access to value-based care, broadening Humana's Medicare Advantage provider network in greater Houston

Humana and Kelsey-Seybold Clinic Team up to Expand Access to Value-based Care, Broadening Humana's Medicare Advantage Provider Network in the Greater Houston Area

Anthem

Centene

The Health insurance industry is poised to grow on the back of a better regulatory environment. Aging demography, automation plus mergers and acquisitions are other catalysts.

News for Humana Stock (HUM)